• MindCept

Covid-19: India looks to lure more than 1,000 US companies out of China

India is seeking to lure US businesses, including medical devices giant Abbott Laboratories, to relocate from China as President Donald Trump's administration steps up efforts to blame Beijing for its role in the coronavirus pandemic.


The government in April reached out to more than 1,000 companies in the US and through overseas missions to offer incentives for manufacturers seeking to move out of China, according to Indian officials who asked not to be identified, citing rules on speaking with the media. India is prioritizing medical equipment suppliers, food processing units, textiles, leather and auto part makers among more than 550 products covered in the discussions, they said.



Officials have told companies that India is more economical in terms of securing land and affordable skilled labor than if they moved back to the US or Japan, even if overall costs are still higher than China. They have also offered an assurance that India will consider specific requests on changes to labor laws, which have proved a major stumbling block for companies, and said the government is considering a request from e-commerce companies to postpone a tax on digital transactions introduced in this year's budget.


Tax, labor laws


India's trade ministry has sought detailed feedback from US companies on changes needed to make the country's tax and labor laws more favorable to companies, said one of the officials. Modi's federal government is working with states to ensure long term solutions, the official added, including developing land banks to ensure a quick start for units.


India expects to win over US companies involved in healthcare products and devices, and is in talks with Medtronic Plc and Abbott Laboratories on relocating their units to the country, an official said. Medtronic spokesman Ben Petok and Abbott spokeswoman Darcy Ross didn't immediately respond to emails seeking comment. Both Medtronic and Abbott have a presence in India, which may make it easier for them to move their China supply chains to the country, according to an official. They're based out of financial center Mumbai and already work with large Indian hospital groups. India's trade ministry spokesman didn't respond to an email seeking comment on the effort to lure US companies. The push by Modi's government comes as India tries to regain lost ground after many companies chose countries like Vietnam over India as an alternative destination when Trump started his trade war with China. Modi has tried to shore up US investments and improve ties through corporate tax cuts, two massive public rallies with Trump in Houston and India, and a $3 billion defense deal. Secretary of State Michael Pompeo last month said the US was working with India, Australia, Japan, New Zealand, South Korea and Vietnam on how to "restructure these supply chains to prevent something like this from ever happening again." The administration was "turbocharging" an initiative to remove global supply chains from China, Reuters reported this week, with one official saying it's pushing for an "Economic Prosperity Network" of trusted partners. 'Replace China' "My read is that the network, if it pans out, will look to India and Vietnam to replace China in the global supply chain network," said Derek Grossman, researcher at the Washington-based RAND Corporation who held positions in the US Intelligence Community for more than a decade. "This would be a rough fit in terms of replacing China's immense manufacturing capabilities, but perhaps the US has high hopes that India and Vietnam can quickly ramp up to at least equal Chinese capacity." India in April partially lifted a ban on the export of hydroxychloroquine and paracetamol following a request from Trump. It also approved 130 billion rupees ($1.7 billion) worth of investments to make more bulk drugs and medical devices, and to boost local manufacturing of drug intermediates and active pharmaceutical ingredients to cut dependence on imports from China. "India is a bigger market than Vietnam or Cambodia so it should be a bigger draw for investors looking to move operations out of China," said Ajay Sahai, director general and chief executive officer of the Federation of Indian Exporters. "But apart from ensuring land, water and sewerage, the most important change India needs to make is to give a clear guarantee that the government will not introduce retrospective tax amendments." Some states including Maharashtra have ensured that supply chains for foreign manufacturers remained functional through India's national virus lockdown. Others like Tamil Nadu in the south and Uttar Pradesh in the north have offered concessions for those planning to move. "There's abundant capital in the US that's looking for geographies outside, and we can see India responding," said Mukesh Aghi, president of the US-India Strategic and Partnership Forum, a Washington-based group that advocates for policies that further business ties between the countries. "Companies realize that while large supply chains in China may have been economical, there's no point in keeping all your eggs in one basket."

Source: https://m-timesofindia-com.cdn.ampproject.org/c/s/m.timesofindia.com/business/india-business/covid-19-india-looks-to-lure-more-than-1000-us-companies-out-of-china/amp_articleshow/75595358.cms

May 07,2020

2 views
Mindcept-Logo.png

© MINDCEPT CONSULTING

  • Black LinkedIn Icon

DISCLAIMER: The information contained in this website is offered for illustration purposes only and is general information. We make no representations or warranties of any kind (express or implied) with respect to the information, products, services, statements, figures, calculations, plans, images, logos, related graphics and are purely indicative in nature only. Whilst all reasonable care has been taking in providing all information, however, We or / and our related companies or/ and our representatives, consultants or / and our agents accept no responsibility for its completeness, accuracy, reliability, suitability or availability of any information contained herein for any action taken in reliance thereon by any party. Any reliance on information as contained in this website does not constitute an offer, inducement, representation, warranty or contract and may be relied upon at one’s risk and consequences.